跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.60) 您好!臺灣時間:2026/10/13 19:18
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:邱志陞
研究生(外文):Chih-Shen Chiu
論文名稱:開發幾丁聚醣薄膜及其奈米粒子進行培養角膜上皮細胞之研究
論文名稱(外文):Studies on the effect of chitosan membranes and chitosan nanoparticles on the behavior of corneal epithelial cells
指導教授:楊台鴻
學位類別:碩士
校院名稱:國立臺灣大學
系所名稱:醫學工程學研究所
學門:工程學門
學類:綜合工程學類
論文種類:學術論文
論文出版年:2005
畢業學年度:93
語文別:中文
論文頁數:66
中文關鍵詞:幾丁聚醣薄膜、幾丁聚醣奈米粒子
外文關鍵詞:chitosan membranes、chitosan nanoparticles
相關次數:
  • 被引用被引用:0
  • 點閱點閱:274
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
近幾年之內利用組織工程技術來進行角膜上皮細胞的重建與修補,是以羊膜為主要的治療工具,本研究主要是將角膜上皮細胞培養在幾丁聚醣薄膜上,期望相比於羊膜具治療的效能。我們進而將幾丁聚醣作為奈米粒子,並利用奈米粒子的特性去做些相關的研究。
我們利用了MTT、免疫細胞化學染色與器官培養來比較幾丁聚醣薄膜與羊膜培養角膜上皮細胞的差異,由結果可以發現角膜上皮細胞在幾丁聚醣薄膜上具有良好的活性,可以證明幾丁聚醣是ㄧ具有良好生物相容性的生醫材料。而在免疫細胞化學染色與器官培養的部份來看,我們可以發現幾丁聚醣薄膜與羊膜的結果具有ㄧ制性,這也可以證明幾丁聚醣薄膜具有生物方面的活性可讓角膜上皮細胞重建或修補。而在奈米粒子的部份,我們利用了不同的染劑去證實胞飲作用;並將幾丁聚醣奈米粒子當作基因轉殖的載體,去與微脂粒做比較;也做了不同大小奈米粒子下對角膜上皮細胞的MTT與LDH影響,發覺幾丁聚醣奈米粒子並不具有明顯的毒性且在130nm的奈米粒子影響下,角膜上皮細胞的數目有增加的趨勢。
In recent years, amniotic membranes transplantation is the most important advancement of treatment modality to treat ocular surface diseases. However, there are a lot of flaws for amniotic membranes transplantation. For example, the ethic issue and contamination of amniotic membrane make us to seek a new material to replace the usage of amniotic membrane. The purpose of this project is to evaluate the possibility of replacement of amnitoic membrane with chitosan membrane, which is a biocompatible materials used in many fields of biomedical science. We cultivated bovine corneal epithelial cells on chitosan membranes and evaluated their phenotypes.
MTT assay, indirect immunocytochemical staining and organ culture were used to compare the differences and evaluate the efficacy of treatment of corneal epithelial defects between amniotic membranes and chitosan membranes. According to the MTT assay, we found that the chitosan membrane was a good biomaterial for cultured corneal epithelial cells. In addition, the results of indirect immunocytochemical staining and organ culture, we found that chitosan membrane was compatible and as good as the use of amniotic membrane. Our results indicated that chitosan membrane is a good material for corneal tissue regeneration and repair.
For nanoparticle studies, we used different dyes to study endocytosis of chitosan nanoparticles in cultured cells. We found that chitosan nanoparticles could transfect cultured cells with a less effeciency than the liposome. From the results of MTT and LDH assays, we found that chitosan nanoparticles were low toxic and 130 nm of chitosan nanoparticles were helpful to increase cell numbers.
目錄............................................................................................................I
中文摘要..................................................................................................IV
英文摘要...................................................................................................V
圖表目錄.................................................................................................VII
第一章 背景..............................................................................................1
第二章 文獻回顧......................................................................................6
2-1高分子薄膜...................................................................................6
2-2 羊膜..............................................................................................7
2-3角膜上皮細胞的簡介...................................................................8
2-4幾丁聚醣奈米粒子…...................................................................8
第三章 材料與方法................................................................................10
3-1 實驗材料....................................................................................10
3-2 實驗儀器....................................................................................12
3-3 試劑配製....................................................................................16
3-4幾丁聚醣薄膜的製備.................................................................17
3-5分離純化角膜上皮細胞.............................................................18
3-6角膜上皮細胞的培養.................................................................19
3-6-1薄膜的前處理...................................................................19
3-6-2細胞的培養.......................................................................20
3-7細胞於材料上生長與死亡之評估.............................................20
3-7-1 MTT測試(評估細胞生長的情形)..................................20
3-7-2 LDH測試(評估細胞死亡的情形)..................................21
3-8間接免疫細胞化學染色.............................................................22
3-9器官培養.....................................................................................23
3-10奈米粒子粒徑大小與表面電量的測定...................................24
3-10-1製作幾丁聚醣奈米粒子.................................................24
3-10-2測定大小與電位.............................................................25
3-11奈米粒子的改質........................................................................26
3-11-1接枝螢光染劑.................................................................26
3-11-2接枝近紅外光染劑....….................................................27
3-11-3與脫氧核糖核酸結合...........................................……..27
3-12大小不同奈米粒子的MTT與LDH測試.................................29
第四章 結果與討論................................................................................30
4-1角膜上皮細胞在不同基材上培養情形:...................................30
4-2角膜上皮細胞對於不同大小奈米粒的活性與毒性測試.........31
4-3奈米粒子大小與濃度的關係.....................................................33
4-4角膜上皮細胞吞噬奈米粒子的情形.........................................34
4-5微脂粒與奈米粒子當作載體之轉殖.........................................36
4-6大小不同奈米粒子的MTT與LDH測試.................................37
4-7器官培養的情形………………………….................................40
第五章 結論............................................................................................43
參考文獻..................................................................................................44
附圖..........................................................................................................48
1.Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 1998; 82: 235–240

2.Lee SH, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997; 123: 303–312

3.Ray Jui-Fang Tsai, Lien-Min Li, Jan-Kan Chen. Reconstruction of Damaged Corneas by transplantation of autologous limbal epithelail cells. The new England Journal of Medicine 2000, 343: 86-93

4.Yasemin A. Katircioglu, Koray Budak, Sibel Salvarli and Sunay Duman. Amniotic membrane transplantation to reconstruct the conjunctival surface in cases of chemical burn. Jpn J Ophthalmol 2003; 47: 519–522

5.Tseng SCG, Prabhasawat P, Lee SH. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol 1997; 124: 765– 774

6.Tsai RJF, Tseng SCG. Human allograft limbal transplantation for corneal surface reconstruction. Cornea 1994;13:389-400.

7.Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens Johnson syndrome. Am J Ophthalmol 1996; 122: 38 –52

8.Honovar S, Bansal A, Sangwan V, Rao G. Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology 2000; 107: 975–979.

9.Yong-Woo Cho, Yong-Nam Cho, Sang-Hun Chung, Gyeol Yoo, Sohk-Won Ko. Water-soluble chitin as a wound healing accelator. Biomaterials 20, 2139-2145(1999)

10.Pamela J. VandeVord, Howard W.T Matthew, Stephen P.Desilva, rt al. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 59; 585-590(2002)

11.K.Y. Lee, I.C. Kwon, Y.H. Kim, W.H. Jo, S.Y. Jeong. Preparation of chitosan self-aggregates as a gene delivery system. Journal of Controlled release, 51, 213-220(1998)

12.Angela M. De Campos, Alejandro Sanchez, Maria J. Alonso. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporine A Int. J. Phar. 224(2001)159-168

13.Strathmann, H., “Membrane separation processes,” J. Membrane Sci. 9 (1981), 121-189

14.O. Gris, A. Lopez-Navidad, F. Caballero, Z. del Campo, and A. Adan. Amniotic membrane transplantation for ocular surface pathology: long-term results. Transplantation Proceedings, 35, 2031-2035(2003)

15.Gerrit Borchard. Chitosans for gene delivery. Advanced Drug Delivery Reviews, 52, 145-150(2001)

16.YI ZHANG, RASHID A. AKHTAR. Effect of Epidermal Growth Factor on Phosphatidylinositol 3-kinase Activity in Rabbit Corneal Epithelial Cells. Exp. Eye Res., 63, 265-275(1996)

17.Volonte, C., Ciotti, M.T., and Battistini, L., “Development of a method for messuring cell number: Application to CNS primary neuronal culture,” Cytometry, 17(1994), 274-276

18.Benjamin, H.S., Li, L., and Yoon, P., “Thymic peptide protects vascular endotheial cells from hydrogen peroxide-induced oxidant injury,” Life. Sci., 52(1993), 1787-1796

19.P.CALVO, C.REMUNAN-LOPEZ, J. L. VILA-JATO, AND M.J. ALONSO, “NOVEL Hydrophilic Chitosan-Polyethylene Oxide Nanoparticles as Protein Carriers”, Journal of Applied Polymer Science 63, 125-132(1997)

20.Min Huang, Zengshuan Ma, Eugene Khor, and Lee-Yong Lim, “Uptake of FITC-Chitosan Nanoparticles by A549 Cells”, Pharmaceutical Research 19, 1488-1494(2002)

21.Umar Mahmood, Ching-Hsuan Tung, Alexei Bogdanov, Ralph Weissleder, “Near-Infrared Optical Imaging of Protease Activity for Tumor Detection”, Radiology 213, 866-870(1999)

22.Toshinori Sato, Tsuyoshi Ishii, Yoshio Okahata, “In vitro gene delivery mediated by chitosan. Effect of PH, serum, and molecular mass of chitosanon the transfection efficiency”, biomaterials 22, 2075-2080(2001)

23.Karin Corsi, Fatiha Chellat, L’Hocine Yahia, Julio C. Fernandes, “Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles”, biomaterials 24, 1255-1264(2003)

24.M. Thanou, B.I. Florea, M. Geldof, H.E. Junginger, G. Borchard, “Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines”, biomaterials 23, 153-159(2002)

25.Yutaka Ishino, Yoichiro Sano, Takahiro Nakamura, Che J. Connon, Helen Rigby, Nigel J. Fullwood, Shigeru Kinoshita, “Amniotic Membrane as a Carrier for Cultivated Human Corneal Endothelial Cell Transplantation”, Investigative Ophthalmology & Visual Science 45, 800-806(2004)

26.Andrew George, William G. Pitt, “Comparison of corneal epithelial cellular gowth on synthetic cornea materials”, Biomaterials 23, 1369-1373(2002)

27.Deborah F. Sweeney, Ruo Zhong Xie, Margaret D. M. Evans, Antti Vannas, Simon D. Tout, Hans J. Griesser, Graham Johnson, Jack G. Steele, “A Comparison of Biological Coatings for the Promotion of Corneal Epithelialization of Synthetic Surface In Vivo”, Investigative Ophthalmology & Visual Science 44, 3301-3309(2003)

28.M. D. M. Evans, S. Taylor, B. A. Dalton, D. Lohmann, “Polymer design for corneal epithelial tissue adhesion: Pore density”, J Biomed Mater Res 64A, 357-364(2003)

29.John G. Steele, Graham Johnson, Hans J. Griesser, P. Anne Underwood, “Mechanism of initial attachment of corneal epithelail cells to polymericsurfaces”, Biomaterials 18, 1541-1551(1997)

30.Margaret D. M. Evans, John G. Steele, “Polymer surface chemistry and a novel attachment mechanism in corneal epithelial cells”, J Biomed Mater Res 40,621-630(1997)

31.Der-Yuan Wang, Yi-Jen Hsueh, Vivian C. Yang, Jan-Kan Chen, “Propagation and Phenotypic Preservation of Rabbit Limbal Epithelial Cells on Amniotic Membrane”, Investigative Ophthalmology & Visual Science 44,4698-4704(2003)

32.Sandra W. Ryeom, David Paul, Daniel A. Goodenough, “Truncation Mutants of the Tight Junction Protein ZO-1 Disrupt Corneal Epithelial Cell Morphology”, Molecular Biology of the Cell 11, 1687-1696(2000)

33.MAYUMI MOCHIZUKI, YUICHI KADOYA, YOKO WAKABAYASHI, KOZUE KATO, IKUKO OKAZAKI, MASANORI YAMADA, TAKU SATO, NOBUO SAKAIRI, NORIO NISHI, MOTOYOSHI NOMIZU, “Laminin-1 peptide-conjugated chitosan membranes as a novel approach for cell engineering”, The FASEB Journal 17, 875-877(2003)
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關論文
 
1. 13.羅際棠(1999),銀行授信與經營,三民書局。14.劉坤霖(1999),國內消費金融創新策略建立之研究,義守大學管理研究所,碩士論文。15.邱志洲、謝邦昌(2000),STATISTIC應用系列叢書(六)--類神經網路分析。16.李昇暾(2000),「以資料採礦深化顧客關係管理」,電子化企業:經理人報告,頁37-42。17.李馨蘋(2000),住宅抵押貸款違約風險之探討,中華管理評論,Vol.3, No.3,頁111-126。18.呂美慧(2000),銀行授信評等模式–Logistic Regres
2. 5.施恩(1994),房屋貸款還款速度之研究,國立台灣大學商學研究所,碩士論文。6.江百信、張金鵬(1995),“我國購屋貸款放款條件之研究”,住宅學報,第三期,頁1-20。7.黃小玉(1988),銀行放款信用評估模式之研究─最佳模式之選擇,淡江大學管理科學研究所,碩士論文。8.杜慶麟(1996),銀行授信決策應用類神經網路之研究-抵押貸款之實證研究,國立清華大學,工業工程研究所,碩士論文。9.建華銀行(1997),回復型房屋貸款產品計劃,頁1-3。10.汪忠平(1997),以類神經網路建立財務危機預測模
3. 38.王濟川、郭志剛(2003),Logistic回歸模型方法與應用,五南出版。39.吳昇洋(2003),用資料採礦技術評估客服中心顧客關係管理之績效,國立清華大學,工業工程與工程管理研究所,碩士論文。40.李海麟(2003),銀行消費者房屋貸款授信評量之實證分析,國立中正大學國際經濟研究所,碩士論文。41.李桂榮(2003),自用住宅購屋貸款特性與逾期還款關係之研究,國立高雄第一科技大學金融營運研究所,碩士論文。42.康清贊(2003),銀行放款評估之知識擷取:類神經網路之應用,國立中正大學資訊管理研究
4. 28.薛琦(2002),消費者貸款,台灣金融研訓院。29.薛琦(2002),授信一般規章介紹,台灣金融研訓院。30.台灣金融研訓院(2002),銀行授信法規輯要,增修訂四版。31.陳柏蒼(2002),「淺談金融機構如何運用市場區隔之行銷策略強化競爭力」,建華金融季刊,第19期,頁43-52。32.郭敬和(2002),商業銀行授信評等之研究-類神經模糊理論之應用,靜宜大學,會計研究所,碩士論文。33.賴耐志(2002),應用資料探勘於市場區隔分析,國立台北科技大學, 商業自動化與管理研究所,碩士論文。34.